FAP+ fibroblasts have also been identified in PDAC as tumor-promoting CAFs, performing possibly through stromal-derived factor 1 (SDF-1) and C-C motif chemokine ligand 2 (CCL2) dependent manner (Yang et al., 2016a; McAndrews et al., 2022). The gene discussed is CCL2; the disease is neoplasm.